Telix Pharmaceuticals | TLX - Loan Capital



Telix Pharmaceuticals reported AUD551.82M in Loan Capital for its fiscal semester ending in December of 2024.


Loan Capital Change Date
Cochlear AUD 203.5M 1.4M Dec/2024
CSL USD 9.33B 1.91B Dec/2024
Integral Diagnostics AUD 341.63M 1.98M Jun/2024
Mayne Pharma AUD 31.64M 1.47M Jun/2024
Medical Developments International AUD 1.76M 150K Dec/2024
Mesoblast 102.44M 8.18M Jun/2024
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Pacific Edge NZD 1.77M 744K Sep/2024
Paradigm Biopharmaceuticals AUD 100K 79.43K Dec/2024
Polynovo AUD 12.84M 857K Jun/2024
PYC Therapeutics AUD 827.09K 24.09K Dec/2024
Ramsay Health Care AUD 10.69B 359.3M Dec/2024
ResMed USD 658.39M 4.47M Jun/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024